Oncology Nursing Drug Guide

Developer: Atmosphere Apps, Inc.

Category: Medical

Add App to Comparison

1.3K installs

25 ratings

104 monthly active users

$<10K monthly revenue est.

IAP 100% · Ad 0%

Install Trends

Monthly +6.00

Declining

ASO Keyword Dashboard

Tracking 102 keywords for Oncology Nursing Drug Guide in Apple App Store

Developer: Atmosphere Apps, Inc. Category: medical Rating: 4.48

Oncology Nursing Drug Guide tracks 102 keywords (3 keywords rank; 99 need traction). Key metrics: 0% top-10 coverage, opportunity 70.3, difficulty 41.5, best rank 66.

Tracked keywords

102

3 ranked • 99 not ranking yet

Top 10 coverage

Best rank 66 • Latest leader —

Avg opportunity

70.3

Top keyword: patient

Avg difficulty

41.5

Lower scores indicate easier wins

Opportunity leaders

patient

Opportunity: 73.0 • Difficulty: 38.6 • Rank —

Competitors: 33
64.0
assist

Opportunity: 73.0 • Difficulty: 40.6 • Rank —

Competitors: 102
66.4
release

Opportunity: 73.0 • Difficulty: 47.2 • Rank —

Competitors: 140
64.7
cancellation

Opportunity: 73.0 • Difficulty: 43.1 • Rank —

Competitors: 238
63.7
especially

Opportunity: 73.0 • Difficulty: 40.8 • Rank —

Competitors: 112
65.6

Unranked opportunities

patient

Opportunity: 73.0 • Difficulty: 38.6 • Competitors: 33
assist

Opportunity: 73.0 • Difficulty: 40.6 • Competitors: 102
release

Opportunity: 73.0 • Difficulty: 47.2 • Competitors: 140
cancellation

Opportunity: 73.0 • Difficulty: 43.1 • Competitors: 238
especially

Opportunity: 73.0 • Difficulty: 40.8 • Competitors: 112

High competition keywords

new

Total apps: 182,994 • Major competitors: 3,792

Latest rank: — • Difficulty: 56.1
free

Total apps: 164,931 • Major competitors: 3,886

Latest rank: — • Difficulty: 55.9
information

Total apps: 112,143 • Major competitors: 1,128

Latest rank: — • Difficulty: 52.4
account

Total apps: 81,354 • Major competitors: 2,100

Latest rank: — • Difficulty: 53.0
offers

Total apps: 74,543 • Major competitors: 1,355

Latest rank: — • Difficulty: 51.3

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
drug	71	100	38	55 1,824 competing apps Median installs: 350 Avg rating: 4.1	99	66	21 major competitor apps
atmospheric	70	100	34	52 1,301 competing apps Median installs: 1,380 Avg rating: 4.2	169	168	24 major competitor apps
nursing	71	100	32	53 1,512 competing apps Median installs: 400 Avg rating: 4.1	188	188	11 major competitor apps
free	65	100	56	87 164,931 competing apps Median installs: 800 Avg rating: 4.2	—	—	3,886 major competitor apps
new	65	100	56	88 182,994 competing apps Median installs: 600 Avg rating: 4.1	—	—	3,792 major competitor apps
communication	71	100	44	72 19,535 competing apps Median installs: 250 Avg rating: 4.1	—	—	140 major competitor apps
subscription	68	100	52	79 51,569 competing apps Median installs: 1,300 Avg rating: 4.2	—	—	1,536 major competitor apps
within	68	100	51	81 67,459 competing apps Median installs: 550 Avg rating: 4.1	—	—	1,296 major competitor apps
active	71	100	46	73 22,788 competing apps Median installs: 650 Avg rating: 4.1	—	—	493 major competitor apps
information	66	100	52	84 112,143 competing apps Median installs: 350 Avg rating: 4.1	—	—	1,128 major competitor apps
payment	69	100	51	78 45,600 competing apps Median installs: 900 Avg rating: 4.2	—	—	1,238 major competitor apps
valuable	72	100	43	69 14,148 competing apps Median installs: 400 Avg rating: 4.2	—	—	156 major competitor apps
provide	68	100	49	79 55,996 competing apps Median installs: 350 Avg rating: 4.1	—	—	558 major competitor apps
key	69	100	48	78 46,710 competing apps Median installs: 450 Avg rating: 4.2	—	—	535 major competitor apps
account	67	100	53	82 81,354 competing apps Median installs: 1,000 Avg rating: 4.2	—	—	2,100 major competitor apps
understanding	72	100	42	69 14,215 competing apps Median installs: 350 Avg rating: 4.2	—	—	89 major competitor apps
patients	72	100	38	62 5,417 competing apps Median installs: 200 Avg rating: 4.1	—	—	36 major competitor apps
effective	72	100	43	70 16,268 competing apps Median installs: 400 Avg rating: 4.2	—	—	142 major competitor apps
managed	72	100	44	70 14,309 competing apps Median installs: 1,200 Avg rating: 4.1	—	—	436 major competitor apps
provides	67	100	49	81 72,728 competing apps Median installs: 350 Avg rating: 4.0	—	—	564 major competitor apps
patient	73	100	39	64 6,705 competing apps Median installs: 250 Avg rating: 4.1	—	—	33 major competitor apps
current	68	100	52	81 68,542 competing apps Median installs: 750 Avg rating: 4.1	—	—	1,468 major competitor apps
assist	73	100	41	66 9,257 competing apps Median installs: 350 Avg rating: 4.1	—	—	102 major competitor apps
release	73	100	47	65 7,389 competing apps Median installs: 700 Avg rating: 4.1	—	—	140 major competitor apps
includes	70	100	47	76 33,776 competing apps Median installs: 450 Avg rating: 4.1	—	—	403 major competitor apps

App Description

Written especially for nurses caring for patients with cancer, the Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

Completely revised and updated, the Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.

New drugs include:

apalutamide (Erleada™)
calaspargase pegol-mknl (Asparlas™)
Daunorubicin and cytarabine liposome for injection (Vyxeos®)
glucarpidase (Voraxaze®)
alpelisib (Piqray®)
binimetinib (Mektovi®)
dacomitinib (Vizimpro®)
Duvelisib (Copiktra®)
encorafenib (Braftovi®)
erdafitinib (Balversa™)
lorlatinib (Lorbrena®)
anakinra (Kineret®)
baricitinib (Olumiant®)
sarilumab (Kevzara®)
aprepitant injectable emulsion (Cinvanti®)
granisetron hydrochloride extended-release injection (Sustol®)
letermovir (Prevymis™)
omadacycline (Nuzyra™)
meropenem/vaborbactam (Vabomere™)
Plazomicin (Zemdri™)
baloxavir marboxil (Xofluza™)
imipenem/cilastatin sodium/relebactam (Recarbrio™)
eravacycline (Xerava™)
delafloxacin (Baxdela™)

Subscriptions are $9.99 for one year. Your subscription will auto-renew annually at the end of each year-long term, unless cancelled. Payment will be charged to your iTunes Account at confirmation of purchase. The subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Your account will be charged $9.99 for renewal within 24-hours prior to the end of the current period. Subscriptions may be managed and auto-renewal may be turned off by going to your Account Settings after purchase. No cancellation of the current subscription is allowed during active subscription period. Any unused portion of a free tria